Sulfamethoxydiazine

磺胺对甲氧嘧啶

Report date: 2022/08/05 17:48:21
NME

Base Information

Drug NameSulfamethoxydiazine
Drug Alias NameSulfametoxydiazine磺胺甲肟2-(对氨基苯磺酰氨基)-5-甲氧基嘧啶sulfamethoxydiazineSulfamethoxypyrimidine +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydropteroate synthase inhibitors
TargetsDihydropteroate synthase
Therapy Area/IndicationsUrinary Tract Infections
Global Approved IndicationsUrinary Tract Infections
Approved Indications in ChinaUrinary Tract Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1966/07/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesChengdu First Pharmaceutical Co Ltd
Inactive CompaniesBayer Healthcare Pharmaceuticals Inc
Active IndicationsUrinary Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01ED04
Related LinksWikipediaDrugBankKEGG